Table 1.

Clinicopathologic variables and PPARγ expression of the tumor cohort

CharacteristicsAll cases, n (%)PPARγ low, n (%)PPARγ high, n (%)P
All cases79 (61.2)50 (38.8)
Age at diagnosis (y)
    ≤6473 (56.6)44 (34.1)29 (22.5)0.856
    >6456 (43.4)27 (27.1)16 (16.3)
Tumor stage
    pT15 (3.9)3 (3.2)2 (1.6)0.021*
    pT240 (31.0)30 (23.3)10 (7.8)
    pT378 (60.5)45 (34.9)33 (25.6)
    pT46 (4.7)1 (0.8)5 (3.9)
Nodal status
    pN046 (36.5)31 (24.6)15 (11.9)0.349
    pN180 (63.5)47 (37.3)33 (26.2)
Grade
    G110 (7.8)7 (5.4)3 (2.3)0.118*
    G266 (51.2)44 (34.1)22 (17.1)
    G353 (41.1)28 (21.7)25 (19.4)
Residual tumor status
    R094 (82.5)58 (50.9)36 (31.6)0.452
    R120 (17.5)10 (8.8)10 (8.8)
  • * χ2 for trends.